Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnicorn Asset Management Regulatory News (UAV)

Share Price Information for Unicorn Asset Management (UAV)

Share Price is delayed by 15 minutes
Get Live Data
70.00    0.00 (0.00%)
Bid:
67.00
Ask:
73.00
Spread: 6.00 (8.955%)
Market Cap: £180.27m
UAV Live PriceLast checked at - London Stock Exchange

Intraday Unicorn Asset Management Share Chart

Interim Management Statement

9 Jan 2015 11:47

RNS Number : 7841B
Unicorn AIM VCT PLC
09 January 2015
 



Unicorn AIM VCT plc

Interim Management Statement

For the period from 1 October 2014 to 31 December 2014.

 

 

Introduction

 

The Company has prepared this Interim Management Statement for the three month period ended 31 December 2014, together with relevant information up to the date of publication.

 

Investment Objective

 

The Company's objective is to provide Shareholders with an attractive return from a diversified portfolio of investments, predominantly in the shares of AIM quoted companies, by maintaining a steady flow of dividend distributions to Shareholders from the income as well as capital gains generated by the portfolio.

 

It is also the objective that the Company should continue to qualify as a Venture Capital Trust, so that Shareholders benefit from the taxation advantages that this brings. To achieve this at least 70% of the Company's total assets are to be invested in qualifying investments of which 30% by VCT value (70% for funds raised after 6 April 2011) must be in ordinary shares which carry no preferential rights (save as permitted under VCT rules) to dividends or return of capital and no rights to redemption.

 

Performance

 

As at 31 December 2014, the unaudited Net Asset Value (NAV) was 144.6 pence per share, compared to an audited NAV of 143.7 pence per share as at 30 September 2014. In the three months ended 31 December 2014, NAV therefore increased by 0.6%. By comparison, the FTSE All-Share Index (excluding investment trusts) rose by 0.5%, while the FTSE AIM All-Share Index declined by 6.0%. NAV and Index performance is calculated on a total return basis, after adding back dividends paid. No dividends were paid by the Company during the period.

 

UK equity markets ended the period almost unchanged, but this performance, masks a relatively volatile three months during which the FTSE All-Share Index rose or fell in value by at least 6% on four different occasions. Notwithstanding the increased volatility of the wider market and poor share price performance from a small number of stocks, the total return from the portfolio was positive in the period.

 

The share prices of Eclectic Bars, Photonstar, Pressure Technologies and Tangent all fell by more than 20% as the market reacted to cautious outlook statements from the management teams of these businesses.

 

In contrast, twelve of the holdings in the portfolio increased in value by more than 10%. In percentage terms, the standout performance came from Castleton Technology, a provider of software and managed services, the shares of which rose by 64% in the period following an issue of new equity to help fund a potentially transformational acquisition. In absolute terms, the positive contributions from Abcam (+15.8%), Anpario (+14.9%) and Tracsis (+13.5%) made the greatest impact, being the three largest holdings in the portfolio by value.

 

 

 

Material Transactions

 

Five follow-on investments were made during the period. The total cost of these purchases was just over £2 million.

 

In order to manage stock specific risk effectively and to maintain appropriate cash balances, a partial disposal in Mears Group was also made. This partial realisation generated cash proceeds of £1.6 million.

 

 

 

Top 10 Equity Holdings as at 31 December 2014

 

Stock % of net assets

 

Abcam 8.4%

 

Tracsis 7.4%

Anpario 6.1%

 

Mattioli Woods 4.6%

 

Crawshaw 3.9%

 

Cohort 3.1%

 

Animalcare Group 2.1%

 

WYG 2.1%

 

Unicorn Mastertrust Fund 2.1%

 

Idox 2.0%

 

Total 41.8%

 

 

Share Buy-Backs/Issue of Equity

 

During the period from 1 October 2014 to 31 December 2014, the Company bought back 495,000 of its own ordinary shares at an average price of 128.4 pence per share. The average discount to the net asset value per share at which the shares were bought back during the period was 9.8%.

 

Three allotments were made in the period under review, in connection with the £15 million Offer for Subscription, launched on 17 September 2014. A total of 4,312,888 new Ordinary Shares were issued at prices ranging between 141.9 and 149.9 pence per share.

 

As a result of these transactions, the total number of shares in issue at the period end was 67,986,000.

 

 

Material Events

 

There were no other material events during the period from 1 October 2014 to 31 December 2014.

 

 

 

Contact details for further enquiries:

 

Chris Hutchinson of Unicorn Asset Management Limited (the Investment Manager),

on 020 7253 0889.

 

Jon Carslake at ISCA Administration Services Limited (the Company Secretary)

on 01392 487056 or by e-mail on unicornaimvct@iscaadmin.co.uk

 

 

9 January 2015

 

DISCLAIMER

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website:- www.unicornaimvct.co.uk (or any other website) is incorporated into, or forms part of, this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDMGGMMLKGKZM
Date   Source Headline
1st Apr 202510:07 amRNSTotal Voting Rights
31st Mar 202511:15 amRNSOffer for Subscription - Update
18th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 202512:04 pmRNSOffer Update - Overallotment
11th Mar 20251:01 pmRNSDirector/PDMR Shareholding
11th Mar 202511:15 amRNSIssue of Equity under Offer
6th Mar 202511:14 amRNSNet Asset Value(s)
3rd Mar 202510:05 amRNSTotal Voting Rights
21st Feb 20257:00 amRNSDirector/PDMR Shareholding
21st Feb 20257:00 amRNSIssue of Equity
12th Feb 20251:27 pmRNSResult of AGM
4th Feb 20252:39 pmRNSNet Asset Value(s)
3rd Feb 202510:15 amRNSTotal Voting Rights
28th Jan 202512:14 pmRNSPublication of a Prospectus
17th Jan 20256:01 pmRNSTransaction in Own Shares
10th Jan 20253:31 pmRNSNet Asset Value(s)
2nd Jan 202512:51 pmRNSDirector Declaration
2nd Jan 20257:00 amRNSTotal Voting Rights
17th Dec 20244:18 pmRNSTransaction in Own Shares
9th Dec 20242:17 pmRNSNet Asset Value(s)
6th Dec 20247:00 amRNSFinal Results
29th Nov 202411:59 amRNSDividend Declaration
27th Nov 20247:00 amRNSINTENTION TO LAUNCH AN OFFER
5th Nov 20243:05 pmRNSNet Asset Value(s)
18th Oct 202411:05 amRNSNet Asset Value(s)
2nd Oct 202410:30 amRNSDirectorate Change
1st Oct 20249:45 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSTransaction in Own Shares
9th Sep 20249:56 amRNSNet Asset Value(s)
2nd Sep 202410:02 amRNSTotal Voting Rights
16th Aug 20248:58 amRNSTransaction in Own Shares
13th Aug 20249:38 amRNSDirector/PDMR Shareholding
13th Aug 20249:16 amRNSIssue of Equity
6th Aug 20249:31 amRNSNet Asset Value(s)
8th Jul 20242:00 pmRNSNet Asset Value(s)
1st Jul 202410:12 amRNSTotal Voting Rights
20th Jun 20242:25 pmRNSTransaction in Own Shares
7th Jun 20247:00 amRNSNet Asset Value(s)
23rd May 20247:00 amRNSHalf-year Report
8th May 20249:47 amRNSNet Asset Value(s)
8th Apr 20241:46 pmRNSNet Asset Value(s)
2nd Apr 202410:46 amRNSTotal Voting Rights
18th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 202412:00 pmRNSDirector/PDMR Shareholding
11th Mar 202411:59 amRNSTotal Voting Rights
11th Mar 202411:57 amRNSIssue of Equity
7th Mar 202411:34 amRNSNet Asset Value(s)
1st Mar 202410:54 amRNSTotal Voting Rights
15th Feb 20244:30 pmRNSOffer for Subscription Update
14th Feb 20241:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.